Dual Bronchodilators in Bronchiectasis Study: a randomised controlled trial

<title>Extract</title> Bronchiectasis is characterised by permanent airway dilatation, airway infection, inflammation, chronic sputum production and repeated exacerbations [1] . Prevailing guidelines are largely empirical and note the critical lack of high-quality studies informing practice [2, 3]. Standard care is chest physiotherapy [1, 2, 4, 5] and antibiotics for treatment and prophylaxis of acute exacerbations [1, 2, 6].